Drug Development

Operations for High Throughput Genomic Drug Discovery Begins

Published in Drug Week, June 2nd, 2000

HTS Biosystems, Inc., St. Paul, Minnesota, has begun operations to pursue accelerated development of high throughput, cost-effective molecular detection systems for the rapidly growing pharmaceutical and genomics research markets.

The company has rights to proven technology and a prototype system from its majority shareholder, Quantech, Ltd. (QQQQ) that will enable it to commercialize its Flex CHIP Kinetic Analysis System in 2001.

"HTS Biosystems intends to be the definitive source of high-throughput instrument systems and chemistries in the fields of functional genomics, proteomics, and drug discovery," said Gregory Freitag, HTS. "FLEX CHIP will...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2000-06-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry